Answers are grounded in this paper and cite their sources.
Background: Peripheral blood CD4+ T cell counts are a clinical marker for assessing disease progression in HIV-infected patients as well as in SIV-/SHIV–infected macaques. However, it is clinically debatable about whether this marker is a sole indicator for assessing HIV disease progression and need for ART in HIV-infected individuals. Studies with SIV-or SHIV-infected Indian rhesus macaques and sooty mangabeys have generated the conflicting data regarding the association of CD4+ T cell depletion with viral loads and disease progression. Results: In the present study, we used cynomolgus monkeys, a suitable non-human primate model for chronic HIV infection studies, to determine the effects of the antibody-mediated acute CD4+ cell depletion on viral load as well as on the immunological factors associated with disease progression. We found that as compared with the control animals, CD4+ T cell-depleted animals with chronic SHIV infection showed (i) little alteration in plasma viral load over the period of 22 weeks after the depletion; (ii) increased CD4+ T cell proliferation and turnover of macrophages at the early phase of the depletion, but subsequent decline to the basal levels; and (iii) little impact on the expression of the inflammatory cytokines and CC chemokines associated with disease progression. Conclusions: These findings indicate that the antibody-mediated acute CD4+ T cell depletion had minimal impact on plasma viral load and disease progression in chronically SHIVSF162P3N-infected cynomolgus monkeys. Future investigations are necessary to identify novel and more reliable clinical markers correlated with viremia and disease progression in HIV-infected individuals.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.